A Resource Guide to Investing in Biotechnology
Directory - Encyclopedia - Stock Index - Drugs  

Biotech100 Stock Index

GTX Inc.

About GTX

GTx is a biopharmaceutical company dedicated to the discovery, development and commercialization GTX's drug discovery and development programs are focused on small molecules that selectively modulate the effects of estrogens and androgens, two essential classes of hormones.

GTx’s marketed compound is FARESTON® (toremifene citrate 60mg) tablets for the treatment of metastatic breast cancer.

In two of the clinical programs, the company is developing the same active compound, toremifene citrate, as ACAPODENE™ for two separate indications in men: (1) for the prevention of prostate cancer in high risk men and (2) a clinical trial for the treatment of serious side effects of androgen deprivation therapy for advanced prostate cancer.

In its third clinical program, GTx and its partner, Ortho Biotech Products, L.P., a subsidiary of Johnson & Johnson, are developing andarine, a selective androgen receptor modulator (SARM)

In its fourth clinical program, GTx is developing its second SARM, ostarine, for andropause and other conditions related to aging, including sarcopenia.

In addition, GTx has an extensive preclinical pipeline (see below)


Pipeline for GTX




More on GTX

Home Page

Key Statistics for GTX

Basic Chart for GTX

Analyst Opinion

Analysts Estimates


Biotech100 Index
· What are the Requirements to be listed in the Biotech100 Index?
· See the Biotech100 List

Sponsored Links

Clinical Trials
· What is a Clinical Trial?
·Phase I ,-- Phase II, -- PhaseIII
·What is Randomized Control?
 What is a Double Blind Experiment?
·What is the role of the FDA?


Key Biotech Terms


Biotech Resources


Investing in Stocks
· Small Cap Stocks
· Stocks and Bonds
· Biotech100 Index

Careers and Employment
· Biotechnology and Pharmaceutical
· What are the Fastest Growing Careers?




Copyright © 2005 BIOTECH100.COM. All rights reserved.